YK Bioventures Opportunities Fund I, L.P. 3
3 · CERO THERAPEUTICS HOLDINGS, INC. · Filed Nov 14, 2024
Insider Transaction Report
Form 3
Holdings
- 25,870,783(indirect: By YK Bioventures Opportunities Fund I, L.P.)
Common Stock
Footnotes (1)
- [F1]Securities are held directly by YK Bioventures Opportunities Fund I, L.P. (f/k/a YK Bioventures, LLC) ("YK Opps I"). YK Bioventures Opportunities GP I, LLC ("YK Opps I GP") is the general partner of YK Opps I and may be deemed to beneficially own the shares held by YK Opps I. Mitchell W. Kossar and Gary K. Yeung are managing partners of YK Opps I GP, and may be deemed to share voting and investment power over the shares held by YK Opps I. Each of YK Opps I GP and Messrs. Kossar and Yeung disclaims beneficial ownership of these shares except to the extent of its or his respective pecuniary interest therein.